greeksoup/ stock research

UnitedHealth Group (UNH) FY2022 results: revenue $324.2 billion, up 12.7% on the year

UnitedHealth Group Inc. (UNH) reported revenue of $324.2 billion for fiscal 2022, the year ended 31 December 2022, up 12.7% on the year before. Net income was $20.1 billion, up 16.4%, and diluted earnings per share $21.18. The figures are the company's own, from the 10-K it filed with the SEC on 24 February 2023.

Revenue
$324.2 billion
+12.7% on the year
FY2015FY2022
Operating margin
8.8%
8.3% a year earlier
FY2015FY2022
Net income
$20.1 billion
+16.4% on the year
FY2015FY2022
Diluted EPS
$21.18
+17.1% on the year
FY2015FY2022

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2022 · Q2 FY2022 · Q3 FY2022 · Q4 FY2022

Income statement (profit and loss)

$ millionFY2022FY2021FY2020On the yearLast 8 years
Revenue324,162287,597257,141+12.7%
Cost of revenue33,70331,03430,745+8.6%
Gross profit290,459256,563226,396+13.2%
Gross margin89.6%89.2%88.0%
Selling, general and administrative47,78242,57941,704+12.2%
Operating income28,43523,97022,405+18.6%
Operating margin8.8%8.3%8.7%
Interest expense2,0921,6601,663+26.0%
Pre-tax income26,34322,31020,742+18.1%
Income tax5,7044,5784,973+24.6%
Effective tax rate21.7%20.5%24.0%
Net income20,12017,28515,403+16.4%
Net margin6.2%6.0%6.0%
Diluted EPS$21.18$18.08$16.03+17.1%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2022FY2021FY2020On the yearLast 8 years
Operating cash flow26,20622,34322,174+17.3%
Capital expenditure2,8022,4542,051+14.2%
Free cash flow23,40419,88920,123+17.7%
Free cash flow margin7.2%6.9%7.8%
Cash from investing-28,476-10,372-12,532
Cash from financing4,226-7,455-3,590
Depreciation and amortisation3,4003,1032,891+9.6%
Share-based compensation925800679+15.6%
Buybacks7,0005,0004,250+40.0%
Dividends paid5,9915,2804,584+13.5%
Dividend per share$6.40$5.60$4.83+14.3%
Diluted shares, weighted950m956m961m-0.6%
Shares outstanding at period end934m941m946m-0.7%

Balance sheet

$ millionFY2022FY2021FY2020On the yearLast 8 years
Shareholders' equity81,45075,04568,328+8.5%
Redeemable equity4,8971,4342,211+241.5%
Debt57,62346,00343,467+25.3%
Other liabilities101,73589,72483,283+13.4%
Total liabilities and equity245,705212,206197,289+15.8%
Fixed assets10,1288,9698,626+12.9%
Goodwill93,35275,79571,337+23.2%
Intangible assets14,40110,04410,856+43.4%
Investments48,27445,64644,102+5.8%
Cash and equivalents23,36521,37516,921+9.3%
Receivables17,68114,21612,870+24.4%
Inventory3,5002,900n/a+20.7%
Other assets35,00433,26132,577+5.2%
Total assets245,705212,206197,289+15.8%

10-K for the year ended 31 December 2022, filed 24 February 2023: the filing.